Quarterly ResultMay 20, 2026, 02:46 PM
RADNOSTIX Q1 Net Loss $(1.35)M; Terminates $12.5M DUF6 Asset Sale
AI Summary
RADNOSTIX INC. reported a significant increase in net loss to $(1.35) million for the three months ended March 31, 2026, compared to $(0.11) million in the prior year, with product sales decreasing by 26.55%. The company mutually terminated its $12.5 million asset purchase agreement for its Fluorine Products segment, citing the buyer's inability to secure funding and the company's belief in the assets' appreciated value. RADNOSTIX also noted ongoing liquidity challenges and dependence on key suppliers, alongside efforts to expand its Medical Device segment and strategic partnerships.
Key Highlights
- Terminated $12.5 million DUF6 Asset Sale with American Fuel Resources.
- Q1 2026 net loss increased to $(1,348,086) from $(112,694) in Q1 2025.
- Product sales decreased 26.55% to $2,378,924 in Q1 2026.
- Gross profit fell 43.36% to $1,150,948 in Q1 2026.
- Net cash used in operating activities was $(72,442) in Q1 2026.
- Total current assets decreased to $3.92 million from $4.63 million since Dec 31, 2025.
- Recorded $102,441 out-of-period RSU compensation expense in Q1 2026.
- Extended Series C Preferred Stock redemption date to February 17, 2027.
Price Impact
More from INIS